Literature DB >> 34642808

Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy.

Mengsha Zou1, Dide Wu2, Hongzhang Zhu1, Xiahua Huang1, Xiaojuan Zhao2, Jing Zhao1, Wenhao Fu1, Ruocheng Li1, Bin Li3, Pengxia Wan4, Shubin Hong2, Yanbing Li2, Haipeng Xiao5, Zhiyun Yang6.   

Abstract

OBJECTIVE: To evaluate the ability of quantitative MRI parameters for predicting dysthyroid optic neuropathy (DON).
METHODS: We retrospectively collected and analyzed the clinical features and 3.0 T MRI data of 59 patients with Graves orbitopathy (GO), with (n = 26) and without DON (n = 33). We compared MRI quantitative parameters, including the modified muscle index (mMI), proptosis, volume of intra-orbital fat, mean apparent diffusion coefficient value, and T2 value of the optic nerve among patients with and without DON. A logistic regression analysis was performed to identify the risk factors associated with DON. Moreover, we performed a receiver operating characteristic curve analysis and decision curve analysis to evaluate the diagnostic performance of the identified parameters for DON.
RESULTS: We studied 118 orbits (43 and 75 with and without DON, respectively). The mMI and mean T2 value of the optic nerve were significantly greater in orbits with DON (p < 0.001). A greater mMI at 21 mm (odds ratio (OR), 1.039; 95% confidence interval (CI): 1.019, 1.058) and higher mean T2 value of the optic nerve (OR, 1.035; 95% CI: 1.017, 1.054) were associated with a higher risk of DON. A model combining the mMI at 21 mm and mean T2 values for the optic nerve effectively predicted DON in patients with GO, with a sensitivity and specificity of 95.3% and 76%, respectively.
CONCLUSION: A quantitative MRI parameter combining the mMI at 21 mm and mean T2 value of the optic nerve can be an effective imaging marker for identifying DON. KEY POINTS: • Patients with GO and DON had greater mMI than those without DON. • Optic nerves in patients with DON demonstrated an increased T2 value. • The quantitative MRI parameter combining the mMI at 21 mm and mean T2 value of the optic nerve is the most effective method for diagnosing DON.
© 2021. European Society of Radiology.

Entities:  

Keywords:  Dysthyroid optic neuropathy; Graves orbitopathy; Magnetic resonance imaging; Muscle index; Optic neuropathy

Mesh:

Year:  2021        PMID: 34642808     DOI: 10.1007/s00330-021-08300-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Diagnostic Utility of Optic Nerve Measurements with MRI in Patients with Optic Nerve Atrophy.

Authors:  B Zhao; N Torun; M Elsayed; A-D Cheng; A Brook; Y-M Chang; R A Bhadelia
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-14       Impact factor: 3.825

2.  Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis.

Authors:  Simon J Hickman; Claudia A M Wheeler-Kingshott; Stephen J Jones; Katherine A Miszkiel; Gareth J Barker; Gordon T Plant; David H Miller
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

3.  Extraocular muscle sampled volume in Graves' orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences.

Authors:  Ludovico M Garau; Daniele Guerrieri; Flaminia De Cristofaro; Alice Bruscolini; Giuseppe Panzironi
Journal:  Acta Radiol Open       Date:  2018-06-25
  3 in total
  4 in total

1.  Increased Orbital Muscle Fraction Diagnosed by Semi-Automatic Volumetry: A Risk Factor for Severe Visual Impairment with Excellent Response to Surgical Decompression in Graves' Orbitopathy.

Authors:  Christine Steiert; Sebastian Kuechlin; Waseem Masalha; Juergen Beck; Wolf Alexander Lagrèze; Juergen Grauvogel
Journal:  J Pers Med       Date:  2022-06-06

2.  Multi-Parametric Diffusion Tensor Imaging of The Optic Nerve for Detection of Dysthyroid Optic Neuropathy in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Ping Liu; Ban Luo; Lin-Han Zhai; Hong-Yu Wu; Qiu-Xia Wang; Gang Yuan; Gui-Hua Jiang; Lang Chen; Jing Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

3.  Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.

Authors:  Shan-Shan Yang; Yi-Shan Wu; Wei-Chao Chen; Jun Zhang; Su-Ming Xiao; Bao-Yu Zhang; Zhi-Qiao Liu; En-Ni Chen; Xu Zhang; Pu-Yun OuYang; Fang-Yun Xie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09-01       Impact factor: 9.236

4.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.